9.healthfinancesummit by charles yu

8
Health Financing Summit 04.14.10

description

Charles Y. Yu, MD, MSc, FPCP, FPCCP is an internationally recognized expert on TB particularly on public-private mix DOTS (PPMD). He is currently a member of the Core Group of the WHO DOTS Expansion Committee, PPMD Subgroup, WHO consultant on TB-PPMD and immediate past President of the Global Alliance for TB Drug Development Stakeholders Association. He is also a member of the International Union Against Tuberculosis (IUATLD) TB Education Working Group. He was senior TB adviser and training and certification adviser of the Philippine TB Initiatives in the Private Sector (Phil. TIPS), where he played a pivotal role in convincing key stakeholders (6 major professional societies, association of medical schools, allied health schools) in getting involved in TB control and the integration of DOTS in their training. In particular he worked closely with the Association of Phil. Medical Colleges (APMC) in the integration of the teaching of TB & DOTS in the medical curriculum. Likewise, the curriculum for teaching TB & DOTS in the medical technology, pharmacy and nursing schools were also created. Dr. Yu left his practice between 2003-2006 to devote himself totally to the TB project because he felt the time was right to finally turn the tide against TB in the country by helping consolidate public-private sector efforts to achieve TB control .

Transcript of 9.healthfinancesummit by charles yu

Page 1: 9.healthfinancesummit by charles yu

Health Financing Summit

04.14.10

Page 2: 9.healthfinancesummit by charles yu

HEALTH FINANCING: FROM A HOSPITAL

PROFIT FOR SERVICE PERSPECTIVE

A HOSPITAL & PATIENT-ORIENTED VIEW

Charles Y. Yu,MD,MScFPCP,FACPhon,FPCCPVice Chancellor for Lasallian Mission & Linkages

Past VP Medical Services/ Hospital DirectorWHO Consultant for TB PPMD

2009 MOF PCCP & 10 Filipino Outstanding Physicians (JCI Senate,DOH, PHIC,PCSO)

Page 3: 9.healthfinancesummit by charles yu

MAINTAIN CONSERVATIVE RETAINED EARNINGS

INCREASE CONTRIBUTION MARGIN

INCREASE DONATIONS

LEVERAGE MARKET OPPORTUNITY

PROVIDE OUTSTANDING CUSTOMER SERVICE

DEMONSTRATE CONTINUED CLINICAL & ACADEMIC EXCELLENCE (PRODUCT/SERVICE

CORE)

STRIVE FOR OPERATIONAL EXCELLENCE (PRODUCTIVITY)

EASY ACCESS(PLACE-MENT)

ON TIME SERVICE

(PROCESS-ING)

FRIENDLY, ATTENTIV

E & SINCERE INTER-

ACTIONS (PEOPLE/ STAFF)

DEVELOP LEADING EDGE TECHNIQUES &

PROGRAMS

DEVELOP RESEARCH OPPORTUNITIES ALIGNED W/ TARGETED GROWTH AREAS

CLINICAL PRACTICE & ACADEMIC

MANAGEMENT

OPTIMIZE STAFF EFFICIENCY

REDESIGN OPERATIONS FOR EFFICIENCY & EFFECTIVENESS

CONTINUALLY DEVELOP SUBSPECIALIZED CLINICAL

SERVICES

CLEARLY COMMUNICATE

EXPECTATIONS & ACCOUNTABILITIES

ALIGNED W/ STRATEGIC PRIORITIES

CREATE AN ENVIRONMENT TO

SUPPORT "CUSTOMER" & EMPLOYEE ENGAGEMENT

& COMMITMENT TO THE VMV

ALIGN AND RESTRUCTURE ORGANIZATION; RECRUIT, TRAIN

AND RETAIN QUALIFIED STAFF

IMPLEMENT TECHNOLOGY AND DEVELOP FACILITIES AND INFRASTRUCTURE TO

SUPPORT INTERNAL PROCESSES

(PHYSICAL EVIDENCE/ SERVICE VENUE)

DEVELOP LEADERSHIP AND MANAGEMENT

TALENT

FINANCIAL PERSPECTIVE: BUILD A STRONG FINANCIAL BASE TO REALIZE OUR VMV

CUSTOMER PERSPECTIVE: PRIMARY TARGET MARKET WILL PREFER HSC AS COLLEGE AND HOSPITAL OF CHOICE

INTERNAL PROCESSESPERSPECTIVE: ALIGN AND STRENGTHEN INSTITUTION TO TARGET/ PREFERRED TOTAL CUSTOMER EXPERIENCE

LEARNING & GROWTH PERSPECTIVE: ALIGN, DEVELOP AND MANAGE STRATEGIC RESOURCES FOR CONTINUALLY IMPROVING INTERNAL PROCESSES EXECUTION

OPTIMIZE CAPACITY(PRICING)

BRAND AND POSITION BY TOTAL CUSTOMER EXPERIENCE (PROMOTION 1)

CUSTOMER EDUCATION & COMMUNI-

CATION (PROMO-TION 2)

Strategic Theme: Realize DLS-HSI's VMV

*Adapted from St. Mary's Duluth Clinic Health System's Strategy Map (Strategy Maps by Robert S. Kaplan and David P. Norton, P. 59)

Page 4: 9.healthfinancesummit by charles yu

REVENUEHMO 109,537,289 20%COMPANY 29,915,988 5%PROMISSORY NOTE 25,126,829 5%PHILHEALTH 65,687,595 12%CASH PAYMENT 322,028,368 58%

TOTAL REVENUE 552,296,070 100%

REPORT OF REVENUES: June 2009- Feb 2010 UNIVERSITY HOSPITAL

Page 5: 9.healthfinancesummit by charles yu

EXPENSES FOR THE 9 MONTH PEROD 2009-2010

DISBURSEMENT

Salaries,Benefits & Staff Dev 142,918,856 27%

Drugs, Food & Oxygen 121,661,669 23%

Materials & Supplies 89,851,285 17%

Depreciation 29,572,391 6%

Outside Services 27,864,707 5%

Utilities,facilities,Maintenance 34,606,089 7%

Allow. For Bad Debts 9,037,966 2%

Interest Exp 3,111,546 1%

Meetings & PR Expenses 1,252,310 0%

Taxes & Licenses 778,910 0%

Travel & Transportation 991,699 0%

Charity Expenses 874,137 0%

Discount 18,895,605 4%

Miscellaneous 1,550,210 0%

Administrative Exp. 42,598,755 8%

525,566,135 100%

At least 7 -10% (counting the personnel and staffing of the charitywing (20% of beds) expenses go to service cases & discounts

Page 6: 9.healthfinancesummit by charles yu
Page 7: 9.healthfinancesummit by charles yu

Issues & Challenges

• As the first ISO certified hospital in the country , DLSUMC is the pioneer & most experienced in standards, including PHIC

• Many hospitals are having problems complying with PHIC, stds of care etc

• Private-public partnerships needed to improve equity• Danger of 2 worlds: gleaming palaces for the rich and

run-down decrepit hospitals for the poor• Challenge to the new administration• Di KA NAG-IISA

Page 8: 9.healthfinancesummit by charles yu

Health Financing Summit

04.14.10